Remove Career Remove Finance Remove Pharmaceuticals Remove Process
article thumbnail

Why CEOs have Liberal Arts Degrees

Mills Scofield

They are leading global airline, chemical, healthcare, pharmaceutical, and financial companies, among others. History, philosophy, sociology, or any liberal arts degree will not prevent me from pursuing a career in business. Even though they don’t directly align with my career aspirations, they will not take me out of the game.

CEO 70
article thumbnail

Why CEOs have Liberal Arts Degrees

Mills Scofield

They are leading global airline, chemical, healthcare, pharmaceutical, and financial companies, among others. History, philosophy, sociology, or any liberal arts degree will not prevent me from pursuing a career in business. Even though they don’t directly align with my career aspirations, they will not take me out of the game.

CEO 70
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

This Pharma Company Stays Innovative by Doing Two Things

Harvard Business Review

In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers. ” Meanwhile, the company recruited non-scientist talent from finance, consulting, tech, academia, and political campaigns and inserted them into drug-development roles.

article thumbnail

Deep questions: What diving teaches us about uncertainty and risk

Chartered Management Institute

Since founding the Human Diver in 2016, Gareth has given risk training to a wide variety of organisations, from oil and gas and construction to pharmaceuticals and software. In all sectors, tensions exist between competing pressures such as resources, finance, time and workload.

article thumbnail

Many CEOs Aren’t Breakthrough Innovators (and That’s OK)

Harvard Business Review

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8